Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EssentraFRA:HOF -0.80%71 Days Sales Outstanding is 62.89 as of Jun. 2026, which is 5% above its 10-year median of 60.09. GuruFocus rates FRA:HOF with a GF Score™ of 71/100 and a GF Value™ of €1.40 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 1,584 Chemicals companies, Essentra ranks worse than 57.77% on this metric.
Essentra's average Accounts Receivable for the
six
months ended in Jun. 2026 was €66.2 Mil. Essentra's Revenue for the
six
months ended in Jun. 2026 was €192.2 Mil.
Hence, Essentra's Days Sales Outstanding for the
six
months ended in Jun. 2026 was 62.89.
The historical rank and industry rank for Essentra's Days Sales Outstanding or its related term are showing as below:
FRA:HOF'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 48.71 Med: 60.09 Max: 169.74
Current: 70.14
During the past 13 years, Essentra's highest Days Sales Outstanding was 169.74. The lowest was 48.71. And the median was 60.09.
FRA:HOF's Days Sales Outstanding is ranked worse than 57.77% of 1584
companies
in the Chemicals industry
Industry Median: 63.305
vs FRA:HOF: 70.14
Essentra's Days Sales Outstanding
declined
from Jun. 2025 (63.22) to Jun. 2026 (62.89).
Essentra (FRA:HOF) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Essentra Days Sales Outstanding Related Terms
Essentra Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Essentra's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:HOF vs LIN, SHW, ECL: Days Sales Outstanding Comparison
For the Specialty Chemicals subindustry, Essentra's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Essentra Days Sales Outstanding vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Essentra's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Essentra's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Essentra (FRA:HOF) has a Days Sales Outstanding of 62.89 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Essentra and its competitors. This is near median its historical median of 60.09. Over the past decade, Essentra's Days Sales Outstanding has ranged from 48.71 to 169.74. According to the industry distribution chart, Essentra ranks #915 out of 1584 companies in the Chemicals industry, placing it in the top 57.8%.
Is Essentra's Days Sales Outstanding too high?
Essentra's current Days Sales Outstanding of 62.89 is near median its 10-year median of 60.09. Over the past 10 years, this metric has ranged from a low of 48.71 to a high of 169.74. The Chemicals industry median Days Sales Outstanding is 63.31. Essentra's value of 62.89 is 0.7% below this industry median. Based on the distribution chart, Essentra ranks #915 out of 1584 companies in the Chemicals industry, which is below the industry midpoint. Overall, Essentra has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Essentra's Days Sales Outstanding compare to LIN and SHW?
According to the Chemicals industry distribution chart, Essentra ranks #915 out of 1584 companies for Days Sales Outstanding. This places Essentra in the lower half of its industry. The industry median Days Sales Outstanding is 63.31. Essentra's value of 62.89 is 0.7% below this benchmark. Historically, Essentra's own Days Sales Outstanding has ranged from 48.71 to 169.74 over the past decade. While the company's 10-year median is 60.09 vs. the industry median of 63.31, Essentra has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Chemicals company?
The median Days Sales Outstanding among Chemicals companies is 63.31, based on 1,584 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Essentra's current Days Sales Outstanding of 62.89 is 0.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Essentra and its competitors. For the Chemicals industry, the median Days Sales Outstanding is 63.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Essentra's current Days Sales Outstanding is 62.89, which is near median its own 10-year median of 60.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Essentra stock overvalued right now?
Based on GuruFocus' analysis, Essentra (FRA:HOF) is currently considered Modestly Undervalued. The stock's GF Value™ is €1.40, compared to a current price of €1.24 — trading 11.4% below its estimated fair value. The current Days Sales Outstanding is 62.89, which is near median its 10-year median of 60.09 and 0.7% below the Chemicals industry median of 63.31. Essentra's overall GF Score™ is 71/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Essentra (FRA:HOF), the current Days Sales Outstanding is 62.89 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Essentra (FRA:HOF) Overvalued in 2026?
Based on GuruFocus' analysis, Essentra stock appears to be undervalued.
The current stock price of €1.24 is trading 11.4% below its estimated GF Value™ of €1.40.
GuruFocus considers Essentra to be Modestly Undervalued.
Key valuation signals for FRA:HOF:
Days Sales Outstanding: 62.89 (near median its 10-year median of 60.09)
GF Value™: €1.40 vs. price of €1.24 (11.4% below fair value)
Industry Position: 0.7% below the Chemicals median (#915 of 1584)
No single metric tells the full story. See the FRA:HOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Essentra PLC is a provider of essential components and solutions, focusing on the manufacture and distribution of plastic injection moulded, vinyl dip moulded and metal items. It serves various industries, including equipment manufacturing, automotive, fabrication, electronics, medical and renewable energy. Its product offerings include caps, plugs, cable management, fasteners, security seals and access hardware. The company's geographical segments include EMEA, Americas, and APAC. It generates the majority of its revenue from the EMEA region.
71GF Score
Get the complete analysis for FRA:HOF
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:HOF has been successfully added to your 
